Citigroup: Raises Target Price for Bio-Tech-B to HK$500.6, Reiterates "Outperforming the Market" Rating
Citigroup has released a research report that adjusts the valuation based on the latest data. According to the discounted cash flow (DCF) method, the target price for Bio-Tech-B (06990) is raised by 5